Kodiak Sciences Inc (KOD)
3.38
+0.05
(+1.50%)
USD |
NASDAQ |
Apr 24, 16:00
3.38
0.00 (0.00%)
After-Hours: 20:00
Kodiak Sciences Cash from Investing (TTM): 249.23M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 249.23M |
September 30, 2023 | 344.02M |
June 30, 2023 | 402.98M |
March 31, 2023 | -144.82M |
December 31, 2022 | -336.51M |
September 30, 2022 | -414.37M |
June 30, 2022 | -504.80M |
March 31, 2022 | -66.30M |
December 31, 2021 | -38.80M |
September 30, 2021 | 30.92M |
June 30, 2021 | 119.02M |
Date | Value |
---|---|
March 31, 2021 | 181.25M |
December 31, 2020 | 104.83M |
September 30, 2020 | -67.31M |
June 30, 2020 | -124.22M |
March 31, 2020 | -180.32M |
December 31, 2019 | -137.00M |
September 30, 2019 | -24.24M |
June 30, 2019 | -23.74M |
March 31, 2019 | -24.45M |
December 31, 2018 | -0.581M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-504.80M
Minimum
Jun 2022
402.98M
Maximum
Jun 2023
-33.17M
Average
-38.80M
Median
Dec 2021
Cash from Investing (TTM) Benchmarks
Avalo Therapeutics Inc | -0.133M |
Regeneron Pharmaceuticals Inc | -3.185B |
iBio Inc | 8.285M |
Puma Biotechnology Inc | -19.12M |
Dare Bioscience Inc | -0.6294M |